Insider Transactions last 24 months for Soleno Therapeutics, Inc.  -  NSDQ: SLNO

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Manning MeredithChief Commercial Officer03/27/2026DSDirectCOM558$31.72$17,699.0364,507
Manning MeredithChief Commercial Officer03/27/2026DSDirectCOM2,100$31.04$65,180.6465,065
Manning MeredithChief Commercial Officer03/27/2026DSDirectCOM4,864$30.04$146,099.9767,165
Huang Michael F.Sr. VP of Clinical Development03/27/2026DSDirectCOM488$31.72$15,478.7339,823
Huang Michael F.Sr. VP of Clinical Development03/27/2026DSDirectCOM1,838$31.04$57,048.5840,311
Huang Michael F.Sr. VP of Clinical Development03/27/2026DSDirectCOM4,256$30.04$127,837.4742,149
Fulk JenniferCHIEF FINANCIAL OFFICER03/02/2026AADirectCOM39,200$0.00$0.0039,200
Mackaness James HCHIEF FINANCIAL OFFICER01/21/2026AADirectCOM28,600$0.00$0.00131,763
Anish BhatnagarCHIEF EXECUTIVE OFFICER01/21/2026AADirectCOM114,200$0.00$0.00583,656
Yen KristenSEE REMARKS01/21/2026AADirectCOM10,400$0.00$0.0037,639
Manning MeredithChief Commercial Officer01/21/2026AADirectCOM28,600$0.00$0.0072,029
Hirano Patricia CSEE REMARKS01/21/2026AADirectCOM10,400$0.00$0.0022,702
Norrett KevinChief Business Officer01/21/2026AADirectCOM3,500$0.00$0.0017,786
Joshi ManherChief Development Officer01/21/2026AADirectCOM4,100$0.00$0.0020,171
Huang Michael F.Sr. VP of Clinical Development01/21/2026AADirectCOM10,400$0.00$0.0046,405
Mackaness James HCHIEF FINANCIAL OFFICER12/15/2025DFDirectCOM2,013$49.95$100,549.35103,163
Anish BhatnagarCHIEF EXECUTIVE OFFICER12/15/2025DGDirectCOM100,000$0.00$0.00469,456
Anish BhatnagarCHIEF EXECUTIVE OFFICER12/15/2025DFDirectCOM7,620$49.95$380,619.00569,456
Yen KristenSEE REMARKS12/15/2025DFDirectCOM904$49.95$45,154.8027,239
Manning MeredithChief Commercial Officer12/15/2025DFDirectCOM1,922$49.95$96,003.9043,429
Hirano Patricia CSEE REMARKS12/15/2025DFDirectCOM904$49.95$45,154.8012,302
Huang Michael F.Sr. VP of Clinical Development12/15/2025DFDirectCOM812$49.95$40,559.4036,005
Norrett KevinChief Business Officer11/17/2025AADirectCOM14,286$0.00$0.0014,286
Joshi ManherChief Development Officer11/10/2025AADirectCOM16,071$0.00$0.0016,071
Hahn Mark WDirector10/13/2025AADirectCOM10,046$0.00$0.0010,046
1   2  3  4  5  6  7  8  9  Next Last  You are at page 1 of 9 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel